Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 12-2016 | 06-2016 | 12-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 13,980 | -3,580 | -7,440 | -7,710 |
| Depreciation Amortization | 0 | 3,610 | 1,760 | 2,940 | 1,080 |
| Other Working Capital | 0 | -56,200 | -23,170 | 234,690 | 237,280 |
| Other Operating Activity | 0 | -2,160 | 70 | 520 | 90 |
| Operating Cash Flow | $0 | $-40,770 | $-24,920 | $230,710 | $230,740 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -1,490 | -260 | -8,200 | -250 |
| Other Investing Activity | 0 | 68,450 | 33,230 | -127,510 | 1,260 |
| Investing Cash Flow | $0 | $66,960 | $32,970 | $-135,710 | $1,010 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -660 | -160 | 3,360 | 1,120 |
| Financing Cash Flow | $0 | $-660 | $-160 | $3,360 | $1,120 |
| Exchange Rate Effect | 0 | -20 | 8 | -60 | -50 |
| Beginning Cash Position | 0 | 169,160 | 172,680 | 71,330 | 71,110 |
| End Cash Position | 0 | 194,650 | 180,560 | 169,630 | 303,940 |
| Net Cash Flow | $0 | $25,490 | $7,880 | $98,300 | $232,830 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | -40,770 | -24,920 | 230,710 | 230,740 |
| Free Cash Flow | 0 | -40,770 | -24,920 | 230,710 | 230,740 |